Zydus Cadila Signs Pact With Gilead To Make Remdesivir

Zydus Cadila Signs Pact With Gilead To Make Remdesivir

[ad_1]

Drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in COVID-19 trials.

[ad_2]

Source link

Rate this post

leave your comment


Your email address will not be published. Required fields are marked *